1089327-21-8

Basic information

• Product Name: 2-butenoic acid, 4-[(2-ethoxyphenyl)amino]-4-oxo-, (2Z)-
• Synonyms: (2Z)-4-[(2-ethoxyphenyl)amino]-4-oxobut-2-enoic acid;2-butenoic acid, 4-[(2-ethoxyphenyl)amino]-4-oxo-, (2Z)-;(Z)-4-[(2-ethoxyphenyl)amino]-4-keto-but-2-enoic acid;(Z)-4-[(2-ethoxyphenyl)amino]-4-oxo-but-2-enoic acid;(Z)-4-[(2-ethoxyphenyl)amino]-4-oxobut-2-enoic acid
• CAS NO: 1089327-21-8
• Molecular Formula: C₁₂H₁₃NO₄
• Molecular Weight: 235.24
• Mol File: 1089327-21-8.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-butenoic acid, 4-[(2-ethoxyphenyl)amino]-4-oxo-, (2Z)-(CAS DataBase Reference)
• NIST Chemistry Reference: 2-butenoic acid, 4-[(2-ethoxyphenyl)amino]-4-oxo-, (2Z)-(1089327-21-8)
• EPA Substance Registry System: 2-butenoic acid, 4-[(2-ethoxyphenyl)amino]-4-oxo-, (2Z)-(1089327-21-8)

Safety Data

• Hazardous Substances Data: 1089327-21-8(Hazardous Substances Data)

Upstream product

• 108-31-6 maleic anhydride 
• 94-70-2 ortho-phenitidine 

Downstream Products

• 36817-57-9 N-(2-ethoxyphenyl)maleimide 

Relevant articles and documents

Methods of treating conditions associated with an Edg-2 receptor

In one aspect, the present invention provides a method for modulating an Edg-2 receptor mediated biological activity in a cell. A cell expressing the Edg-2 receptor is contacted with an modulator of the Edg-2 receptor, which modulates the Edg-2 receptor mediated biological activity. In another aspect, the present invention provides a method for modulating Edg-2 receptor mediated biological activity in a subject. A therapeutically effective amount of an modulator of the Edg-2 receptor is administered to the subject.